Kids with HIV get continued access to lifesaving meds in new study
NCT ID NCT06337032
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study offers continued access to HIV medications for children and adolescents who completed a previous Gilead HIV treatment study. About 350 participants will receive their study drug or switch to a standard HIV medication, and researchers will monitor for side effects. The goal is to ensure uninterrupted treatment and track safety.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baylor College of Medicine
RECRUITINGKampala, Uganda
-
Be Part Yoluntu Centre
RECRUITINGPaarl, 7626, South Africa
-
Enhancing Care Foundation
RECRUITINGDurban, 3629, South Africa
-
Faculty of Medicine - Mahidol University
ACTIVE_NOT_RECRUITINGBangkok Noi, 10700, Thailand
-
Helios Salud
ACTIVE_NOT_RECRUITINGBuenos Aires, C1141 ACG, Argentina
-
Hospital del Niño
ACTIVE_NOT_RECRUITINGPanama City, 0816-00383, Panama
-
Joint Clinical Research Centre
RECRUITINGKampala, 10005, Uganda
-
Khon Kaen University
ACTIVE_NOT_RECRUITINGKhon Kaen, 40002, Thailand
-
MU-JHU Research Collaboration/MU-JHU Care Ltd
RECRUITINGKampala, 256, Uganda
-
Perinatal HIV Research Unit
RECRUITINGSoweto, 2013, South Africa
-
Rahima Moosa Mother and Child Hospital
RECRUITINGJohannesburg, 2112, South Africa
-
The Aurun Institute
RECRUITINGPretoria, 0087, South Africa
-
University of Stellenbosch
RECRUITINGCape Town, 7505, South Africa
-
University of Zimbabwe Clinical Research Centre
RECRUITINGHarare, Zimbabwe
-
WITS RHI Research Centre
RECRUITINGJohannesburg, 2038, South Africa
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single HIV pill tame the epidemic in africa?
- Could a shorter drug course beat a longer one for a deadly fungal infection?
- A kinder, more personal touch may help people with HIV stay in care — a large trial in zambia puts it to the test
- Can tracking HIV's genetic fingerprints reveal where the epidemic is heading?
- Can a new drug, GS-0415, help keep HIV in check? a First-in-Human trial aims to find out
- Could a shot replace daily HIV pills? new trial tests injectable combo